InvestorsHub Logo
Followers 826
Posts 119567
Boards Moderated 14
Alias Born 09/05/2002

Re: semi_infinite post# 17174

Tuesday, 09/18/2018 12:39:33 PM

Tuesday, September 18, 2018 12:39:33 PM

Post# of 29293
I was only joking. I like ENTA's chances in NASH because the company's drug-designers have proven expertise in liver diseases, but the NASH program is not the reason I'm long.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.